Final answer:
DDVAP is primarily used in children with enuresis to manage bed-wetting issues by reducing urine production during sleep. It also treats central diabetes insipidus and certain bleeding disorders.
Step-by-step explanation:
Desmopressin (DDVAP) is commonly used in the population of children with enuresis. This medication is a synthetic form of vasopressin, the hormone that reduces urine production during sleep. By promoting the retention of water, DDVAP decreases urine production and is often prescribed to manage bed-wetting issues in children, which provides them with a non-invasive treatment option for nighttime enuresis. It is also used in the treatment of central diabetes insipidus and in patients with hemophilia A and von Willebrand's disease for its ability to increase levels of von Willebrand factor and factor VIII.